SCM
STDY

Stonepine Capital Management’s SteadyMed Ltd STDY Stock Holding History

Stonepine Capital Management’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-721,308
Closed -$2.34M – 38
2018
Q1 		$2.34M Buy
721,308
+103,583
+17% +$342K 1.26% 19
2017
Q4 		$2.29M Buy
+617,725
New +$2M 1.37% 19

Other funds holding STDY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Stonepine Capital Management's STDY Position: Q2 2018 in Review

Stonepine Capital Management sold out of SteadyMed Ltd (STDY) in Q2 2018, closing a stake of 721,308 shares — an estimated $2.34M sold.

Stonepine Capital Management first reported a position in STDY in Q4 2017 and held it in 2 quarters. The position peaked at $2.34M in Q1 2018. 30 funds tracked by Wall St. Rank hold STDY as of Q2 2018.

  • Stonepine Capital Management reported no remaining SteadyMed Ltd position as of Q2 2018 after selling out during the quarter.
  • Stonepine Capital Management sold 721,308 SteadyMed Ltd shares in Q2 2018, an estimated $2.34M.
  • Stonepine Capital Management first reported a position in SteadyMed Ltd in Q4 2017 and held it in 2 quarters.
  • Stonepine Capital Management's SteadyMed Ltd position peaked at $2.34M in Q1 2018.
  • 30 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q2 2018.

Based on Stonepine Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.